UA98605C2 - Новый способ предотвращения или лечения инфекции m. tuberculosis - Google Patents
Новый способ предотвращения или лечения инфекции m. tuberculosisInfo
- Publication number
- UA98605C2 UA98605C2 UAA200711587A UAA200711587A UA98605C2 UA 98605 C2 UA98605 C2 UA 98605C2 UA A200711587 A UAA200711587 A UA A200711587A UA A200711587 A UAA200711587 A UA A200711587A UA 98605 C2 UA98605 C2 UA 98605C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tuberculosis infection
- fusion protein
- preventing
- treating
- mtb72f
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 4
- 201000008827 tuberculosis Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 108020001507 fusion proteins Proteins 0.000 abstract 3
- 102000037865 fusion proteins Human genes 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000007420 reactivation Effects 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67654905P | 2005-04-29 | 2005-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA98605C2 true UA98605C2 (ru) | 2012-06-11 |
Family
ID=40006338
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200711587A UA98605C2 (ru) | 2005-04-29 | 2006-04-27 | Новый способ предотвращения или лечения инфекции m. tuberculosis |
| UAA201111598A UA107788C2 (en) | 2005-04-29 | 2006-04-27 | A fusion protein of m. tuberculosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201111598A UA107788C2 (en) | 2005-04-29 | 2006-04-27 | A fusion protein of m. tuberculosis |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN105903008B (zh) |
| UA (2) | UA98605C2 (zh) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2133100B1 (en) * | 2000-06-20 | 2011-10-05 | Corixa Corporation | MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof |
| US20030175294A1 (en) * | 2001-03-13 | 2003-09-18 | Corixa Corporation | Heterologous fusion protein constructs comprising a Leishmania antigen |
| AU2003213118A1 (en) * | 2002-02-15 | 2003-09-09 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
-
2006
- 2006-04-27 UA UAA200711587A patent/UA98605C2/ru unknown
- 2006-04-27 UA UAA201111598A patent/UA107788C2/ru unknown
- 2006-04-27 CN CN201610086198.9A patent/CN105903008B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN105903008A (zh) | 2016-08-31 |
| UA107788C2 (en) | 2015-02-25 |
| CN105903008B (zh) | 2020-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013502449A1 (en) | Novel method for preventing or treating m tuberculosis infection | |
| CY1110886T1 (el) | Συνθεσεις για την καταπολεμηση της αντοχης στα αντιβιοτικα με μεσολαβηση β-λακταμασης, χρησιμοποιωντας αναστολεις β-λακταμασης χρησιμους για ενεση | |
| TW200630093A (en) | Dose forms | |
| CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
| BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
| NO20071711L (no) | Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddel | |
| EA201490378A1 (ru) | ЛЕЧЕНИЕ РАССЕЯННОГО СКЛЕРОЗА С ИСПОЛЬЗОВАНИЕМ КОМБИНАЦИИ ЛАХИНИМОДА И ИНТЕРФЕРОНА-β | |
| PE20190351A1 (es) | Agente terapeutico del sindrome de hunter y metodo de tratamiento | |
| ECSP044985A (es) | Azitromicina de dosis única para infecciones respiratorias | |
| EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
| UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
| WO2005030109A3 (en) | Regimen for the administration of rifamycin-class antibiotics | |
| EA200401303A1 (ru) | Лекарственные средства, содержащие стероиды и новое антихолинергическое средство | |
| UA98605C2 (ru) | Новый способ предотвращения или лечения инфекции m. tuberculosis | |
| ATE315041T1 (de) | Salz von morphin-6-glucuronid | |
| CY1115823T1 (el) | Νεα μεθοδος προληψης ή θεραπειας μολυνσης m. tuberculosis | |
| WO2005082396A3 (en) | Use of mda-7 to inhibit infection by pathogenic organisms | |
| DK1677808T3 (da) | Kombinationspræparat til behanding af sepsis | |
| TH1701007800A (th) | ตัวยับยั้งเมทัลโล-บีตา-แลคทาเมส | |
| WO2015027040A3 (en) | Methods and compositions for treating schistosome infection |